Clinical Safety of a Novel Milk Protein Peptide

PHASE1CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

February 28, 2007

Conditions
Drug Safety
Interventions
DIETARY_SUPPLEMENT

Hydrolyzed milk protein mixture

Take twice a day, dosage 6 ml-21 ml based on weight, mix with 1/2 cup of milk.

DIETARY_SUPPLEMENT

Glycerol placebo

"Participants ingested 6ml-21ml of placebo mixed with 1/2 cup milk twice daily. The supplements were prepared in liquid form and packaged in generic bottles for double blind administration. The placebo was a starch-based placebo matched for color, texture, and taste to the active supplement.~A food diary is maintained daily."

Trial Locations (1)

76706

Baylor University Center for Exercise, Nutrition, and Preventive Health Research, Waco

Sponsors
All Listed Sponsors
collaborator

Texas A&M University

OTHER

collaborator

Baylor University

OTHER

lead

Ambryx Biotechnology

INDUSTRY

NCT01412658 - Clinical Safety of a Novel Milk Protein Peptide | Biotech Hunter | Biotech Hunter